Skip to main content
. 2017 Jul 21;8:489. doi: 10.3389/fphar.2017.00489

FIGURE 6.

FIGURE 6

Inhibitory effect of toddalolactone on CCl4-induced liver fibrosis. (A,D) Healthy control group; (B,F) Model group; (C,F) Toddalolactone treatment group. Images in (A–C) are 100× magnification, whereas images in (D–F) are 400× magnification.